🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort

PLoS Biology(2022)10.1371/journal.pbio.3001531Source: DataRank Database

SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort is a research paper published in PLoS Biology (2022). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (49 grants)Impact (FWCI 3.38)OA: goldTopics (96)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Rachel Lowe ORCID,Stephanie Fischinger ORCID,Michael de St. Aubin ORCID,Sameed M. Siddiqui ORCID,Diana Dayal ORCID

Live enrichment

PubMed:35143473 PMC:PMC8865659 OpenAlex:https://openalex.org/W4211015794

Medical Research Council

Grant: MR/N013638/1

DTP Bid Led by London Sch of Hygiene and Trop Medicine

Wellcome Trust

Grant: 206250/Z/17/Z

National Institute for Health Research

Grant: NIHR200908

Centers for Disease Control and Prevention

Grant: U01 U01GH002238

Translational Research Institute for Space Health

Grant: NNX16AO69A

Foundation for the National Institutes of Health

Grant: 3R37AI080289-11S1

Defining humoral correlates of immunity against COVID-19

Foundation for the National Institutes of Health

Grant: R01AI146785

Foundation for the National Institutes of Health

Grant: U19AI42790-01

Foundation for the National Institutes of Health

Grant: U19AI135995-02

Foundation for the National Institutes of Health

Grant: 1U01CA260476-01

Immunologic Signatures of SARS-CoV-2 Vaccination and Disease

Wellcome Trust

Grant: 208812/Z/17/Z

Gates Foundation

Grant: INV-001754

Gates Foundation

Grant: INV-003174

Medical Research Council

Grant: MC_PC_19065

Understanding the dynamics and drivers of the COVID-2019 epidemic using real-time outbreak analytics

National Institute for Health Research (NIHR)

Grant: NIHR200929

NINDS NIH HHS

Grant: R01 NS110424

Gates Foundation

Grant: INV-016832

National Institute for Health Research (NIHR)

Grant: 16/136/46

European Research Council

Grant: 757699

What is Tuberculosis? Challenging the Current Paradigm of Tuberculosis Natural History using Mathematical Modelling Techniques

NIAID NIH HHS

Grant: R37 AI080289

Wellcome Trust

Grant: 206471/Z/17/Z

Medical Research Council

Grant: MR/V027956/1

Investigating SARS-CoV-2 Transmission in UK Jewish Communities

NIAID NIH HHS

Grant: U19 AI135995

National Institute for Health Research (NIHR)

Grant: 16/137/10

Wellcome Trust

Grant: 210758/Z/18/Z

European Research Council

Grant: 757688

HIV-1 acquisition and the future of prevention strategies: deciphering the eclipse phase through modelling and phylogenetics

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: RIA2020EF-2983

CGH CDC HHS

Grant: U01 GH002238

NIAID NIH HHS

Grant: R01 AI042790

NCI NIH HHS

Grant: U01 CA260476

UK Research and Innovation

Grant: MR/S003975/1

Novel methods in data science to quantify viral and environmental triggers of chronic disease exacerbations

National Institutes of Health

Grant: 3R01AI146785-02S1

SARS-CoV-2 Variant Testing

Wellcome Trust

Grant: 206250

Immunity dynamics and epidemiology of cross-reactive pathogens

UK Research and Innovation

Grant: MR/P014658/1

The dynamics of drug resistance within hospital populations of Gram-negative bacteria

Wellcome Trust

Grant: 206471

Estimating the burden of dengue, chikungunya and Zika in Latin America

UK Research and Innovation

Grant: ES/P010873/1

GCRF: RECAP - Research capacity building and knowledge generation to support preparedness and response to humanitarian crises and epidemics

National Institutes of Health

Grant: 6U01GH002238-02M002

Reducing the morbidity and mortality due to acute febrile illnesses in Central America and the Dominican Republic

National Institutes of Health

Grant: 3U19AI135995-04S3

Consortium for Viral Systems Biology (CViSB)

Wellcome Trust

Grant: 208812

Using mathematical modelling to re-think global pneumococcal immunisation strategies.

European Commission

Grant: 101003688

Epidemic intelligence to minimize 2019-nCoV’s public health, economic and social impact in Europe

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 7R01AI042790-05

CHLAMYDIA PNEUMONIAE AND MACROPHAGES IN ATHEROSCLEROSIS

Wellcome Trust

Grant: 221303

Managing COVID-19 epidemics in low- to middle-income and crisis-affected settings: Epidemiological and economic evaluation

Wellcome Trust

Grant: 210758

Real-time modelling for forecasts during infectious disease outbreaks

Musk Foundation

Royal Society Dorothy Hodgkin Fellowship

Wellcome Trust

Massachusetts Consortium on Pathogen Readiness

Wellcome Trust

FWCI

3.38

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001531&type=printable

publisherhttps://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001531&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pbio.3001531

journalhttps://doi.org/10.1371/journal.pbio.3001531

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35143473

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 epidemiological studies0301 basic medicine03 medical and health sciences0303 health sciencesAdolescentAdultAgedAntibodies, ViralCOVID-19COVID-19 Nucleic Acid TestingCOVID-19 Serological TestingHumansLogistic ModelsMiddle AgedPolymerase Chain ReactionProspective StudiesReinfectionSARS-CoV-2Seroepidemiologic StudiesTime FactorsUnited StatesWorkplaceYoung Adult

MeSH Terms

ReinfectionCOVID-19SARS-CoV-2COVID-19 Nucleic Acid TestingCOVID-19 Serological TestingAdolescentAdultAgedAntibodies, ViralHumansMiddle AgedProspective StudiesTime FactorsUnited StatesLogistic ModelsSeroepidemiologic StudiesPolymerase Chain ReactionWorkplaceYoung Adult

Keywords

SerologyOdds ratioOddsLogistic regressionConfoundingCohortBiologyProspective cohort studyCohort studyImmunologyDemographyVirologyInternal medicineMedicineAntibody2800 NeuroscienceAdultTime FactorsAdolescentQH301-705.5Long-term epidemic dynamicsÀrees temàtiques de la UPC::Ciències de la salut::Medicina::Medicina comunitària i salut públicaPublic health. Hygiene. Preventive MedicineMedizin610Antibodies, ViralCOVID-19 (Malaltia)Polymerase Chain ReactionCOVID-19 Serological Testing1100 Agricultural and Biological SciencesYoung AdultCOVID-19 (Disease)Short Reports1300 Biochemistry, Genetics and Molecular BiologySeroepidemiologic StudiesHumansProspective StudiesBiology (General)WorkplaceAgedPCR (Biochemistry)SARS-CoV-2Immunity2400 Immunology and MicrobiologyCOVID-19600Middle AgedUnited StatesSerology.Logistic ModelsCOVID-19 Nucleic Acid TestingReinfection

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being